A. L. Freed, U. Kale, H. Ando, D. T. Rossi, and C. A. Kingsmill, Improving the detection of degradants and 392 impurities in pharmaceutical drug products by applying massspectral and chromatographic searching, J. Pharm

V. Shinde, A. Trivedi, P. R. Upadhayay, N. L. Gupta, D. G. Kanase et al., Degradation mechanism 395 for a trace impurity in quinapril drug by tandem mass and precursor ions studies, J. Mass Spec, vol.21, pp.3156-396, 2007.

O. C?dina, I. Jankovi?, M. Cômor, and S. Vladimirov, Interaction of quinapril anion with cationic surfactant micelles of cetyltrimethylammonium bromide, Journal of Colloid and Interface Science, vol.301, issue.2, pp.692-696, 2006.
DOI : 10.1016/j.jcis.2006.05.025

C. Abbara, G. Aymard, S. Hinh, and B. Diquet, Simultaneous determination of quinapril and its active 400

S. Hillaert and K. De-grauwe, Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis, Journal of Chromatography A, vol.924, issue.1-2, pp.439-404, 2001.
DOI : 10.1016/S0021-9673(01)00714-2

D. Mc-areavey and J. Robertson, Angiotensin converting enzyme inhibitors and moderate hypertension, p.406

K. Makwana, R. V. Dhamecha, and N. Pandya, A rugged and economic method for the estimation of quinapril 408 and its metabolite in human serum by LC/MS/MS detection for clinical trials, Int. J. Pharm. Pharm. Sci, vol.3, issue.409, pp.112-116, 2011.

A. G. Kieback, S. B. Felix, and T. Reffelmann, Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application, Expert Opinion on Drug Metabolism & Toxicology, vol.43, issue.10, pp.1337-412, 2009.
DOI : 10.1093/eurheartj/11.suppl_D.33

W. E. Haefeli, L. Linder, and T. Lüscher, Quinaprilat Induces Arterial Vasodilation Mediated by Nitric Oxide in Humans, Hypertension, vol.30, issue.4, pp.912-917, 1997.
DOI : 10.1161/01.HYP.30.4.912

B. Stanisz, L. Gu, R. G. Strickley, L. H. Chi, and Z. Chowhan, Kinetics of Lisinopril degradation in solid phase, Reaction Kinetics and Catalysis Letters, vol.85, issue.1, pp.145-152, 1990.
DOI : 10.1007/s11144-005-0254-x

R. G. Strickley, G. C. Visor, L. Lin, and L. Gu, An unexpected pH effect on the stability of moexipril 420 lyophilized powder, Pharmaceutical Research, vol.06, issue.11, pp.971-975, 1989.
DOI : 10.1023/A:1015901731275

S. R. Byrn, W. Xu, and A. W. Newman, Chemical reactivity in solid-state pharmaceuticals: formulation implications, Advanced Drug Delivery Reviews, vol.48, issue.1, pp.421-115, 2001.
DOI : 10.1016/S0169-409X(01)00102-8

M. M. Al-omari, M. K. Abdelah, A. A. Badwan, and A. M. Jaber, Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations, Journal of Pharmaceutical and Biomedical Analysis, vol.25, issue.5-6, pp.893-902, 2001.
DOI : 10.1016/S0731-7085(01)00399-5

B. Stanisz, Liquid Chromatographic Studies of the Stability of Benazepril in Pure Form and in Tablets, Journal of Liquid Chromatography & Related Technologies, vol.54, issue.19
DOI : 10.1081/JLC-120029697

. Liq and . Chromatogr, Related Technol, pp.3103-3119, 2005.

U. M. Tripathi, Stress Degradation Behavior of a Polypill and Development of Stability Indicating UHPLC 429

B. Stanisz, The stability of quinapril hydrochloride-a mixture of amorphous and crystalline forms (QHCl- 432 AC) in solid phase, Acta Pol Pharm, vol.60, pp.443-449, 2003.

B. Stanisz, The influence of pharmaceutical excipients on quinapril hydrochloride stability

A. H. Shumet and R. H. Bogner, Solid-state surface acidity and pH-stability profiles of amorphous quinapril 436 hydrochloride and silicate formulations, J. Pharm. Sci, vol.99, pp.2786-2799, 2010.

K. C. Waterman and R. C. Adami, Accelearated aging: prediction of chemical stability of pharmaceuticals, Int, J. Pharm, vol.293, pp.101-125, 2005.

K. Varga, Drug impurity profiling strategies, Talanta, pp.1517-1526, 1997.

S. Gorog, New safe medicines faster: the role of analytical chemistry, TrAC Trends Anal. Chem, vol.22, pp.442-407, 2003.

D. Bonazzi, R. Gotti, V. Andrisano, and V. Cavrini, Analysis of ACE inhibitors in pharmaceutical dosage 446 forms by derivative UV spectroscopy and liquid chromatography (HPLC), J. Pharm. Biomed. Anal, vol.16, pp.447-431, 1997.

S. Hillaerta, Y. Vander-heydenb, and W. Van-den-bossche, Optimisation by experimental design of a capillary electrophoretic method for the separation of several inhibitors of angiotensin-converting enzyme using alkylsulphonates, Journal of Chromatography A, vol.978, issue.1-2, pp.231-242, 2002.
DOI : 10.1016/S0021-9673(02)01388-2

A. R. Kugler, S. C. Olson, and D. E. Smith, Determination of quinapril and quinaprilat by high performance 452 liquid chromatography with radio chemical detection, coupled to liquid scintillation counting spectrometry, p.453

C. Y. Lu, F. T. Liu, and C. H. Feng, Quantitation of quinapril in human plasma by matrix-assisted laser 455

B. Dasandi and S. Shah, Shivprakash, Determination of quinapril and quinaprilat in human plasma by 458 ultraperformance liquid chromatography?electrospray ionization mass spectrometry, Biomed. Chromatogr, vol.459, issue.23, pp.492-498, 2009.

J. A. Prieto, R. M. Jiménez, and R. M. Alonso, Square wave voltammetric determination of the angiotensin 461 converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations, Il Farmaco, vol.462, issue.58, pp.343-350, 2003.

I. Vovk, G. Popovi?, B. Simonovska, A. Albreht, and D. Agbaba, Ultra-thin-layer chromatography mass 464 spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting 465 enzyme inhibitors, J. Chromat A, pp.3089-3094, 1218.

D. Burinsky and S. L. Sides, Mass spectral fragmentation reactions of angiotensin-converting enzyme (ACE) inhibitors, Journal of the American Society for Mass Spectrometry, vol.59, issue.9, pp.1300-1314, 2004.
DOI : 10.1016/j.jasms.2004.05.010

M. Bakshi, S. Singh, and A. Espada, Development of validated stability-indicating assay methods- 469 critical review Ammonium hydrogencarbonate, an excellent buffer for the analysis of basic 471 drugs by liquid chromatography?mass spectrometry at high pH, J. Pharm. Biomed. Anal, vol.2833, issue.987, pp.1011-1040, 2002.

H. Trabelsi, S. Bouabdallah, S. Sabbah, F. Raouafi, K. Bouzouita et al., Study of the cis?trans isomerization of 473 enalapril by reversed-phase liquid chromatography RP-HPLC and NMR 475 study of cis?trans isomerization of enalaprilat, J. Pharm. Biomed. Anal. Bouabdallah, S.; Trabelsi, H.; Bouzouita, K. J. Biochem. Bioph. Methods, vol.8713536, issue.54, pp.189-199, 2000.

V. Lagesson, L. Lagesson-andrasko, J. Andrasko, and F. Baco, Identification of compounds and specific 479 functional groups in the wavelength region 168-330 nm using gas chromatography with UV detection, J

F. Sanchez-rojas and C. Bosch-ojeda, Recent development in derivative ultraviolet/visible absorption 482 spectrophotometry, Analyt. Chim. Acta, vol.635, pp.2004-2008, 2009.

D. Bonazzi, R. Gotti, V. Andrisano, and V. Cavrini, Analysis of ACE inhibitors in pharmaceutical dosage 484 forms by derivative UV spectroscopy and liquid chromatography (HPLC), J. Pharm. Biomed. Anal, vol.16, pp.485-431, 1997.

R. A. Rourick, K. J. Volk, S. E. Klohr, T. Spears, E. H. Kerns et al., Predictive strategy for the rapid structure elucidation of drug degradants, Journal of Pharmaceutical and Biomedical Analysis, vol.14, issue.12, pp.1743-1752, 1996.
DOI : 10.1016/0731-7085(96)01843-2

A. Marí-n, C. Barbas, and . Lc, LC/MS for the degradation profiling of cough???cold products under forced conditions, Journal of Pharmaceutical and Biomedical Analysis, vol.35, issue.5, pp.1035-1045, 2004.
DOI : 10.1016/j.jpba.2004.03.011

A. Gentili, S. Marchese, and D. Perret, MS techniques for analyzing phenols, their metabolites and 493 transformation products of environmental interest, Structural Characterization of Photodegradation Products of Enalapril 495 and Its Metabolite Enalaprilat Obtained under Simulated Environmental Conditions by Hybrid Quadrupole- 496, pp.888-903, 2008.

S. P. Bhardwaj and S. Singh, Study of forced degradation behavior of enalapril maleate by LC and LC???MS and development of a validated stability-indicating assay method, Journal of Pharmaceutical and Biomedical Analysis, vol.46, issue.1, pp.113-120, 2008.
DOI : 10.1016/j.jpba.2007.09.014

A. Elshanawane, S. Mostafa, and M. Elgawish, Application of a Validated, Stability-Indicating LC Method to 500

D. M. Lima, L. D. Santos, and E. M. Lima, Stability and in vitro release profile of enalapril maleate from 502 different commercially available tablets: Possible therapeutic implications, Stress Degradation Studies of Ramipril and Moexipril.HCl, pp.567-573, 2008.

C. A. Beasley, J. Shaw, Z. Zhao, and R. A. Reed, Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulation, Journal of Pharmaceutical and Biomedical Analysis, vol.37, issue.3, pp.559-567, 2005.
DOI : 10.1016/j.jpba.2004.11.021

L. Hany?ová, M. Václavková, J. Dohnal, and J. Klime?, Stability of ramipril in the solvents of different pH, Journal of Pharmaceutical and Biomedical Analysis, vol.37, issue.5
DOI : 10.1016/j.jpba.2004.10.041

R. Ro?kar, Z. Simon?i?, A. Gartner, and V. Kmetec, Stability of new potential ACE inhibitor in the aqueous solutions of different pH, Journal of Pharmaceutical and Biomedical Analysis, vol.49, issue.2, pp.295-303, 2009.
DOI : 10.1016/j.jpba.2008.11.029

C. Goolcharran and R. T. Borchardt, Kinetics of Diketopiperazine Formation Using Model Peptides, Journal of Pharmaceutical Sciences, vol.87, issue.3
DOI : 10.1021/js970325m

A. Radzicka and R. Wolfenden, Rates of Uncatalysed Peptide Bond Hydrolysis in Neutral solution and the 514, p.513

B. Jan?i?, M. Medenica, D. Ivanovi?, S. Jankovi?, and A. Malenovi?, Monitoring of fosinopril sodium 516 impurities by liquid chromatography?mass spectrometry including the neural networks in method evaluation, p.517

Z. Simon?i?, P. Zupan?i?, R. Ro?kar, A. Gartner, K. Kogej et al., Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations, International Journal of Pharmaceutics, vol.342, issue.1-2, pp.145-151, 2007.
DOI : 10.1016/j.ijpharm.2007.05.016

Z. Simoncic, R. Rokar, A. Gartner, K. Kogej, V. Kmetec et al., The use of microcalorimetry and HPLC for 522 the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous 523 solutions Kinetics of the acidic and enzymatic 525 hydrolysis of benazepril HCl studied by LC, Int. J. Pharm. J. Pharm. Biomed. Anal, vol.356, issue.27, pp.200-205, 2002.

L. Gu, G. Robert, A. S. Strickley, S. Sahle, R. Gauges et al., Preformulation stability studies of the new Dipeptide Angiotensin- 527 Converting Enzyme Inhibitor RS-10029, Pharm. Res. Pahle, J.; Simus, N Bioinformatics, vol.5, issue.22, pp.765-771, 1988.